Sign In
Buy NVCN
$30.03
+0 (+0%)
At Close: Jul 07, 2023
Neovasc to Report Second Quarter 2021 Financial Results on August 10, 2021
09:05am, Tuesday, 27'th Jul 2021
VANCOUVER, July 27, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (NASDAQ, TSX: NVCN), will report financial results for the second quarter ended June 30, 2021 on Tuesday, August 10 20
Neovasc Announces New Appointments in Regulatory and Clinical Leadership
09:05am, Tuesday, 13'th Jul 2021
Neovasc Team Grows with Addition of Industry Veterans Lisa Becker as VP, Regulatory Affairs, Global Angina Therapies and Sarah Gallagher as VP of Clinical Affairs
Real World Study Shows Neovasc's Reducer Is Safe, Efficacious In Patients With Refractory Angina
10:41am, Friday, 18'th Jun 2021
Neovasc Inc (NASDAQ: NVCN) has announced the publication of an article highlighting the long-term outcomes of patients suffering from refractory angina treated with the Neovasc Reducer system in th
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - June 18, 2021) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today announced the publication of an
Neovasc Provides Corporate Update
03:29pm, Thursday, 10'th Jun 2021
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - June 10, 2021) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today announced that the Company has i
Neovasc Provides Corporate Update
03:06pm, Thursday, 10'th Jun 2021
VANCOUVER and MINNEAPOLIS, June 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced that the Company has implemente
Neovasc Reducer System Receives First National Reimbursement in Europe
09:05am, Monday, 07'th Jun 2021
NHS England Provides National Coverage
Neovasc Inc. Reports Results of Annual General Meeting of Shareholders
04:52pm, Thursday, 03'rd Jun 2021
Vancouver, British Columbia--(Newsfile Corp. - June 3, 2021) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") is pleased to announce the results of the votes on matters considere
Neovasc Inc. Reports Results of Annual General Meeting of Shareholders
04:45pm, Thursday, 03'rd Jun 2021
Vancouver, BC, Canada, June 03, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) is pleased to announce the results of the votes on m
Neovasc Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency
04:05pm, Tuesday, 25'th May 2021
VANCOUVER and MINNEAPOLIS, May 25, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) announced today that it has received written n
Neovasc Provides Update on German Litigation
04:05pm, Thursday, 20'th May 2021
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - May 20, 2021) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") reported today that the Higher Regional C
Neovasc to Sponsor Symposium on Reducer at EuroPCR
09:35am, Thursday, 13'th May 2021
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - May 13, 2021) - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVCN) today announced that it will sponsor a s
Neovasc to Sponsor Symposium on Reducer at EuroPCR
09:11am, Thursday, 13'th May 2021
VANCOUVER and MINNEAPOLIS, May 13, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced that it will sponsor a sympos
MedTech Round Up: Update On Products By Conformis, Medtronic, Orthofix, Neovasc
01:35pm, Monday, 10'th May 2021
The FDA has given 510(k) clearance for Conformis Inc's (NASDAQ: CFMS) Identity Imprint Knee Replacement System, available in both cruciate-retaining (CR) and posterior stabilized (PS) versions. I
Neovasc Announces First Patient Enrollment in COSIMA Trial
09:05am, Monday, 10'th May 2021
VANCOUVER and MINNEAPOLIS, May 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire ‒ Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced that the first patient has been e
